Brexpiprazole for schizophrenia and as adjunct for major depressive disorder

Brexpiprazole - Mechanism of Action and Clinical Application

Rexulti (Brexpiprazole) for the Treatment of Major Depressive Disorder (MDD) and Schizophrenia - Clinical Trials Arena

Full article: Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study

Brexpiprazole for schizophrenia and as adjunct for major depressive disorder

Brexpiprazole: Most Up-to-Date Encyclopedia, News & Reviews

The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open

Brexpiprazole-impurities

Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning

A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder, Acta Neuropsychiatrica

PDF) The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and asadjunctive treatment in patients with major depressive disorder: An analysis of short-term and long-term studies

PDF) Brexpiprazole for the Treatment of Schizophrenia: A Review of this Novel Serotonin-Dopamine Activity Modulator